Skip to main content
Solid Biosciences Inc. logo

Solid Biosciences Inc. — Investor Relations & Filings

Ticker · SLDB ISIN · US83422E2046 US Professional, scientific and technical activities
Filings indexed 661 across all filing types
Latest filing 2021-03-23 Major Shareholding Noti…
Country US United States of America
Listing US SLDB

About Solid Biosciences Inc.

https://www.solidbio.com/

Solid Biosciences is a precision genetic medicine company focused on advancing a portfolio of gene therapy candidates. The company develops treatments for rare and devastating neuromuscular and cardiac diseases, including Duchenne muscular dystrophy, Friedreich’s ataxia, catecholaminergic polymorphic ventricular tachycardia (CPVT), and various forms of dilated cardiomyopathy. In addition to its therapeutic pipeline, Solid Biosciences develops enabling technologies, such as innovative libraries of genetic regulators, to improve gene therapy delivery. The company's mission is to improve the lives of patients by uniting experts in science, technology, and disease management.

Recent filings

Filing Released Lang Actions
AMENDMENT NO. 2 TO SCHEDULE 13D
Major Shareholding Notification
2021-03-23 English
SC 13D/A
Major Shareholding Notification
2021-03-23 English
OWNERSHIP DOCUMENT
Director's Dealing
2021-03-23 English
Regulatory Filings 2021
Regulatory Filings
2021-03-22 English
8-K
Regulatory Filings
2021-03-19 English
424B5
Prospectus
2021-03-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.